Researchers Seek Ways to Minimize Off-Target Effects
Literature Review: Dials for Cas9
Methods to Control Cas9-Based Technologies Across Numerous Dimensions Is Still Lacking
Opening Up Relieves Downstream Bottlenecks
Celebrate the Downstream Improvements That Have Been Achieved, Even If They Fail to Match Upstream Improvements
Top 10 European Biopharma Clusters
The Continent’s Key Academic and Industrial Centers for Drug Development
Limiting Noninvasive Prenatal Testing
A new report on noninvasive prenatal testing (NIPT) by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers. In addition, the Council calls for better information and support, a moratorium on the use of NIPT in sequencing the whole genome of fetuses and a ban on its use in finding out the sex of the fetus.
The Council considered, at this early stage of its use, how NIPT could change the way we view pregnancy, disability, and difference, and what the wider consequences of its increasing use might be. The report recommends that NIPT should only be used for significant medical conditions and impairments that affect the child at birth or in early life, as this information can allow women and couples to make meaningful reproductive choices.